Harte-Hanks (NASDAQ: HHS) reported Q2 EPS of ($0.05), $0.27 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $38.6 million versus the consensus estimate of $47.5 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.